Working Group 4 meeting. EU-COST Action CM1105 - Overcoming cisplatin and oxaliplatin resistance in vitro using small-molecule osmium antineoplastics

Activity: Academic and Industrial eventsGuest lecture or Invited talk

Period2013
Held atEU-COST